Health
Push to get $3.5m drug approved to save kids’ lives – Fraser Coast Chronicle
Parents are fighting to make breakthrough gene therapy — which costs $3.5m for a one-off dose — affordable, and to have all Aussie kids screened.
It is one of the most expensive drugs to ever hit the market, but at $3.5 million per one-off dose, it can mean the difference between life and death for a baby born with spinal muscular atrophy (SMA).
Zolgensma, a gene therapy, is approved by the Therapeutic Good Administration (TGA) but is currently facing a Pharmaceutical Benefits Advisory Board (PBAC) decision on whether to list it for subsidy on the Pharmaceutical Benefits Scheme.
One in 35 people carry the gene mutation for SMA.
SMA leads…
-
Business22 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General22 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Noosa News8 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
General22 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts